ERK1/2 MAP kinases promote cell cycle entry by rapid, kinase-independent disruption of retinoblastoma-lamin A complexes

Journal of Cell Biology

Volumn 191, Issue 5, 2010, Pages 967-979

  Rodríguez, Javier ^a   Calvo, Fernando ^a   González, José M ^b   Casar, Berta ^a   Andrés, Vicente ^b   Crespo, Piero ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIN A; MITOGEN ACTIVATED PROTEIN KINASE 3; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL TRANSFORMATION; PHOSPHORYLATION; PRIORITY JOURNAL; RETINOBLASTOMA; TUMOR CELL;

ANIMALS; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; LAMIN TYPE A; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN;

RUMEX;

EID: 78649658934     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.201004067     Document Type: Article

References (55)

1. Ajenjo, N., D.S. Aaronson, E. Ceballos, C. Richard, J. León, and P. Crespo. 2000. Myeloid leukemia cell growth and differentiation are independent of mitogen-activated protein kinase ERK1/2 activation. J. Biol. Chem. 275:7189-7197. doi:10.1074/jbc.275.10.7189 (Pubitemid 30146269)
2. Andrés, V., and J.M. González. 2009. Role of A-type lamins in signaling, transcription, and chromatin organization. J. Cell Biol. 187:945-957. doi:10.1083/jcb.200904124
3. Arozarena, I., D.S. Aaronson, D. Matallanas, V. Sanz, N. Ajenjo, S.P. Tenbaum, H. Teramoto, T. Ighishi, J.C. Zabala, J.S. Gutkind, and P. Crespo. 2000. The Rho family GTPase Cdc42 regulates the activation of Ras/MAP kinase by the exchange factor Ras-GRF. J. Biol. Chem. 275:26441-26448. doi:10.1074/jbc.M002992200
4. Balmanno, K., and S.J. Cook. 1999. Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene. 18:3085-3097. doi:10.1038/sj.onc.1202647
5. Boban, M., J. Braun, and R. Foisner. 2010. Lamins: 'structure goes cycling'. Biochem. Soc. Trans. 38:301-306. doi:10.1042/BST0380301
6. Broers, J.L., B.M. Machiels, H.J. Kuijpers, F. Smedts, R. van den Kieboom, Y. Raymond, and F.C. Ramaekers. 1997. A- and B-type lamins are differentially expressed in normal human tissues. Histochem. Cell Biol. 107:505-517. doi:10.1007/s004180050138
7. Camps, M., A. Nichols, C. Gillieron, B. Antonsson, M. Muda, C. Chabert, U. Boschert, and S. Arkinstall. 1998. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science. 280:1262-1265. doi:10.1126/science.280.5367.1262
8. Casar, B., V. Sanz-Moreno, M.N. Yazicioglu, J. Rodríguez, M.T. Berciano, M. Lafarga, M.H. Cobb, and P. Crespo. 2007. Mxi2 promotes stimulusindependent ERK nuclear translocation. EMBO J. 26:635-646. doi:10.1038/sj.emboj.7601523
9. Chambard, J.C., R. Lefloch, J. Pouysségur, and P. Lenormand. 2007. ERK implication in cell cycle regulation. Biochim. Biophys. Acta. 1773:1299-1310. doi:10.1016/j.bbamcr.2006.11.010
10. Cheng, M., V. Sexl, C.J. Sherr, and M.F. Roussel. 1998. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc. Natl. Acad. Sci. USA. 95:1091-1096. doi:10.1073/pnas.95.3.1091
11. Cohen-Armon, M., L. Visochek, D. Rozensal, A. Kalal, I. Geistrikh, R. Klein, S. Bendetz-Nezer, Z. Yao, and R. Seger. 2007. DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation. Mol. Cell. 25:297-308. doi:10.1016/j.molcel.2006.12.012
12. D'Abaco, G.M., S. Hooper, H. Paterson, and C.J. Marshall. 2002. Loss of Rb overrides the requirement for ERK activity for cell proliferation. J. Cell Sci. 115:4607-4616. doi:10.1242/jcs.00161
13. Daksis, J.I., R.Y. Lu, L.M. Facchini, W.W. Marhin, and L.J. Penn. 1994. Myc induces cyclin D1 expression in the absence of de novo protein synthesis and links mitogen-stimulated signal transduction to the cell cycle. Oncogene. 9:3635-3645.
14. Dorner, D., S. Vlcek, N. Foeger, A. Gajewski, C. Makolm, J. Gotzmann, C.J. Hutchison, and R. Foisner. 2006. Lamina-associated polypeptide 2α regulates cell cycle progression and differentiation via the retinoblastoma-E2F pathway. J. Cell Biol. 173:83-93. doi:10.1083/jcb.200511149
15. Foster, C.R., S.A. Przyborski, R.G. Wilson, and C.J. Hutchison. 2010. Lamins as cancer biomarkers. Biochem. Soc. Trans. 38:297-300. doi:10.1042/BST0380297
16. Gille, H., T. Strahl, and P.E. Shaw. 1995. Activation of ternary complex factor Elk-1 by stress-activated protein kinases. Curr. Biol. 5:1191-1200. doi:10.1016/S0960-9822(95)00235-1
17. González, J.M., A. Navarro-Puche, B. Casar, P. Crespo, and V. Andrés. 2008. Fast regulation of AP-1 activity through interaction of lamin A/C, ERK1/2, and c-Fos at the nuclear envelope. J. Cell Biol. 183:653-666. doi:10.1083/jcb.200805049
18. Ivorra, C., M. Kubicek, J.M. González, S.M. Sanz-González, A. Alvarez-Barrientos, J.E. O'Connor, B. Burke, and V. Andrés. 2006. A mechanism of AP-1 suppression through interaction of c-Fos with lamin A/C. Genes Dev. 20:307-320. doi:10.1101/gad.349506
19. Johnson, B.R., R.T. Nitta, R.L. Frock, L. Mounkes, D.A. Barbie, C.L. Stewart, E. Harlow, and B.K. Kennedy. 2004. A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation. Proc. Natl. Acad. Sci. USA. 101:9677-9682. doi:10.1073/pnas.0403250101
20. Jones, S.M., and A. Kazlauskas. 2001. Growth-factor-dependent mitogenesis requires two distinct phases of signalling. Nat. Cell Biol. 3:165-172. doi:10.1038/35055073
21. Keenan, S.M., C. Bellone, and J.J. Baldassare. 2001. Cyclin-dependent kinase 2 nucleocytoplasmic translocation is regulated by extracellular regulated kinase. J. Biol. Chem. 276:22404-22409. doi:10.1074/jbc.M100409200
22. Kenworthy, A.K. 2001. Imaging protein-protein interactions using fluorescence resonance energy transfer microscopy. Methods. 24:289-296. doi:10.1006/meth.2001.1189
23. Kerkhoff, E., and U.R. Rapp. 1997. Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1. Mol. Cell. Biol. 17:2576-2586.
24. Krek, W., D.M. Livingston, and S. Shirodkar. 1993. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science. 262:1557-1560. doi:10.1126/science.8248803 (Pubitemid 24036110)
25. Lavoie, J.N., G. L'Allemain, A. Brunet, R. Müller, and J. Pouysségur. 1996. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271:20608-20616. doi:10.1074/jbc.271.34.20608
26. Lee, D.C., K.L. Welton, E.D. Smith, and B.K. Kennedy. 2009. A-type nuclear lamins act as transcriptional repressors when targeted to promoters. Exp. Cell Res. 315:996-1007. doi:10.1016/j.yexcr.2009.01.003
27. Lenormand, P., C. Sardet, G. Pagès, G. L'Allemain, A. Brunet, and J. Pouysségur. 1993. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J. Cell Biol. 122:1079-1088. doi:10.1083/jcb.122.5. 1079
28. Malumbres, M., and M. Barbacid. 2009. Cell cycle, CDKs and cancer: a changing paradigm. Nat. Rev. Cancer. 9:153-166. doi:10.1038/nrc2602
29. Mancini, M.A., B. Shan, J.A. Nickerson, S. Penman, and W.H. Lee. 1994. The retinoblastoma gene product is a cell cycle-dependent, nuclear matrix-associated protein. Proc. Natl. Acad. Sci. USA. 91:418-422. doi:10.1073/pnas.91.1.418
30. Markiewicz, E., T. Dechat, R. Foisner, R.A. Quinlan, and C.J. Hutchison. 2002. Lamin A/C binding protein LAP2alpha is required for nuclear anchorage of retinoblastoma protein. Mol. Biol. Cell. 13:4401-4413. doi:10.1091/mbc.E02-07- 0450
31. Matallanas, D., V. Sanz-Moreno, I. Arozarena, F. Calvo, L. Agudo-Ibáñez, E. Santos, M.T. Berciano, and P. Crespo. 2006. Distinct utilization of effectors and biological outcomes resulting from site-specific Ras activation: Ras functions in lipid rafts and Golgi complex are dispensable for proliferation and transformation. Mol. Cell. Biol. 26:100-116. doi:10.1128/MCB.26.1.100-116.2006
32. Naetar, N., B. Korbei, S. Kozlov, M.A. Kerenyi, D. Dorner, R. Kral, I. Gotic, P. Fuchs, T.V. Cohen, R. Bittner, et al. 2008. Loss of nucleoplasmic LAP2alpha-lamin A complexes causes erythroid and epidermal progenitor hyperproliferation. Nat. Cell Biol. 10:1341-1348. doi:10.1038/ncb1793
33. Nitta, R.T., S.A. Jameson, B.A. Kudlow, L.A. Conlan, and B.K. Kennedy. 2006. Stabilization of the retinoblastoma protein by A-type nuclear lamins is required for INK4A-mediated cell cycle arrest. Mol. Cell. Biol. 26:5360-5372. doi:10.1128/MCB.02464-05
34. Ottaviani, A., S. Rival-Gervier, A. Boussouar, A.M. Foerster, D. Rondier, S. Sacconi, C. Desnuelle, E. Gilson, and F. Magdinier. 2009. The D4Z4 macrosatellite repeat acts as a CTCF and A-type lamins-dependent insulator in facio-scapulo-humeral dystrophy. PLoS Genet. 5:e1000394. doi:10.1371/journal. pgen.1000394
35. Ozaki, T., M. Saijo, K. Murakami, H. Enomoto, Y. Taya, and S. Sakiyama. 1994. Complex formation between lamin A and the retinoblastoma gene product: identification of the domain on lamin A required for its interaction. Oncogene. 9:2649-2653.
36. Pekovic, V., J. Harborth, J.L. Broers, F.C. Ramaekers, B. van Engelen, M. Lammens, T. von Zglinicki, R. Foisner, C. Hutchison, and E. Markiewicz. 2007. Nucleoplasmic LAP2α-lamin A complexes are required to maintain a proliferative state in human fibroblasts. J. Cell Biol. 176:163-172. doi:10.1083/jcb.200606139
37. Raman, M., W. Chen, and M.H. Cobb. 2007. Differential regulation and properties of MAPKs. Oncogene. 26:3100-3112. doi:10.1038/sj.onc.1210392
38. Santamaría, D., C. Barrière, A. Cerqueira, S. Hunt, C. Tardy, K. Newton, J.F. Cáceres, P. Dubus, M. Malumbres, and M. Barbacid. 2007. Cdk1 is sufficient to drive the mammalian cell cycle. Nature. 448:811-815. doi:10.1038/nature06046
39. Sanz-Moreno, V., B. Casar, and P. Crespo. 2003. p38alpha isoform Mxi2 binds to extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase and regulates its nuclear activity by sustaining its phosphorylation levels. Mol. Cell. Biol. 23:3079-3090. doi:10.1128/MCB.23.9.3079-3090.2003
40. Schneider, R., and R. Grosschedl. 2007. Dynamics and interplay of nuclear architecture, genome organization, and gene expression. Genes Dev. 21:3027-3043. doi:10.1101/gad.1604607
41. Seth, A., E. Alvarez, S. Gupta, and R.J. Davis. 1991. A phosphorylation site located in the NH2-terminal domain of c-Myc increases transactivation of gene expression. J. Biol. Chem. 266:23521-23524.
42. Shapiro, P.S., A.M. Whalen, N.S. Tolwinski, J. Wilsbacher, S.J. Froelich-Ammon, M. Garcia, N. Osheroff, and N.G. Ahn. 1999. Extracellular signal-regulated kinase activates topoisomerase IIalpha through a mechanism independent of phosphorylation. Mol. Cell. Biol. 19:3551-3560.
43. Shimi, T., K. Pfleghaar, S. Kojima, C.G. Pack, I. Solovei, A.E. Goldman, S.A. Adam, D.K. Shumaker, M. Kinjo, T. Cremer, and R.D. Goldman. 2008. The A- and B-type nuclear lamin networks: microdomains involved in chromatin organization and transcription. Genes Dev. 22:3409-3421. doi:10.1101/gad.1735208
44. Soule, H.D., J. Vazguez, A. Long, S. Albert, and M. Brennan. 1973. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51:1409-1416.
45. Soule, H.D., T.M. Maloney, S.R. Wolman, W.D. Peterson Jr., R. Brenz, C.M. McGrath, J. Russo, R.J. Pauley, R.F. Jones, and S.C. Brooks. 1990. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 50:6075-6086.
46. Sullivan, T., D. Escalante-Alcalde, H. Bhatt, M. Anver, N. Bhat, K. Nagashima, C.L. Stewart, and B. Burke. 1999. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J. Cell Biol. 147:913-920. doi:10.1083/jcb.147.5.913
47. Van Berlo, J.H., J.W. Voncken, N. Kubben, J.L. Broers, R. Duisters, R.E. van Leeuwen, H.J. Crijns, F.C. Ramaekers, C.J. Hutchison, and Y.M. Pinto. 2005. A-type lamins are essential for TGF-beta1 induced PP2A to dephosphorylate transcription factors. Hum. Mol. Genet. 14:2839-2849. doi:10.1093/hmg/ddi316
48. Villanueva, J., Y. Yung, J.L. Walker, and R.K. Assoian. 2007. ERK activity and G1 phase progression: identifying dispensable versus essential activities and primary versus secondary targets. Mol. Biol. Cell. 18:1457-1463. doi:10.1091/mbc.E06-10-0908
49. Vlcek, S., and R. Foisner. 2007. A-type lamin networks in light of laminopathic diseases. Biochim. Biophys. Acta. 1773:661-674. doi:10.1016/j.bbamcr.2006.07.002
50. Weber, J.D., D.M. Raben, P.J. Phillips, and J.J. Baldassare. 1997. Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem. J. 326:61-68.
51. Weinberg, R.A. 1995. The retinoblastoma protein and cell cycle control. Cell. 81:323-330. doi:10.1016/0092-8674(95)90385-2
52. Weintraub, S.J., K.N. Chow, R.X. Luo, S.H. Zhang, S. He, and D.C. Dean. 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature. 375:812-815. doi:10.1038/375812a0
53. Wolf, I., H. Rubinfeld, S. Yoon, G. Marmor, T. Hanoch, and R. Seger. 2001. Involvement of the activation loop of ERK in the detachment from cytosolic anchoring. J. Biol. Chem. 276:24490-24497. doi:10.1074/jbc.M103352200 (Pubitemid 37412910)
54. Yamamoto, T., M. Ebisuya, F. Ashida, K. Okamoto, S. Yonehara, and E. Nishida. 2006. Continuous ERK activation downregulates antiproliferative genes throughout G1 phase to allow cell-cycle progression. Curr. Biol. 16:1171-1182. doi:10.1016/j.cub.2006.04.044
55. Zalvide, J., and J.A. DeCaprio. 1995. Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation. Mol. Cell. Biol. 15:5800-5810.